Yan‐Hong Deng

Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial

Rui‐Hua Xu, Kei Muro, Satoshi Morita et al. · The Lancet Oncology · 2018 · 157 citations

Medicine, Pharmacology, Clinical Trials +10

Electric‐Field‐Assisted Charge Generation and Separation Process in Transition Metal Oxide‐Based Interconnectors for Tandem Organic Light‐Emitting Diodes

Jinpeng Yang, Yan Xiao, Yan‐Hong Deng et al. · Advanced Functional Materials · 2011 · 120 citations

Engineering, Organic Electronics, Optoelectronic Devices +20

Light extraction enhancement in organic light-emitting diodes based on localized surface plasmon and light scattering double-effect

Yan Gu, Dan-Dan Zhang, Qingdong Ou et al. · Journal of Materials Chemistry C · 2013 · 54 citations

Optical Materials, Engineering, Organic Electronics +22

5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells

Yan‐Hong Deng, Xing-Xiang Pu, Mei-Jin Huang et al. · Chinese Journal of Cancer · 2010 · 43 citations

Expert consensus on maintenance treatment for metastatic colorectal cancer in China

Rui‐Hua Xu, Lin Shen, Jin Li et al. · Chinese Journal of Cancer · 2016 · 15 citations · Full text